期刊文献+

CK-MB、cTn及红细胞分布宽度在非ST段抬高ACS中的意义 被引量:3

CK-MB,cTn,and red cell distribution width in patients withnon-ST-elevated acute coronary syndrome
原文传递
导出
摘要 目的:评价非ST段抬高急性冠状动脉综合征(NSTE-ACS)患者肌酸激酶同工酶(CK-MB)与心肌钙蛋白(cTn)不一致的发生率及临床特点,并探讨红细胞分布宽度(RDW)在其中的价值。方法:NSTE-ACS患者320例,根据标记物特征分为4组:CK-MB-/cTn-组,CK-MB+/cTn-组,CK-MB-/cTn+组,CK-MB+/cTn+组;根据RDW值大小将其分为高RDW组(H-RDW组:RDW>14.5%)和低RDW组(L-RDW组:RDW<14.5%)。分析各组院内心力衰竭(心衰)发生率及死亡率。结果:24.4%患者存在CK-MB与cTn结果不一致,其中CK-MB-/cTn+占15%,CK-MB+/cTn-占9.4%,两者RDW水平差异无统计学意义(P>0.05)。在前述4种组合中,患者住院期间心衰的发生率分别是3.4%、4.4%、6.3%和10.3%,死亡率分别是0.63%、0.94%、1.25%和2.81%;H-RDW与L-RDW组院内心衰发生率分别为16.9%和7.5%,死亡率分别为3.75%和1.88%,均差异有统计学意义(均P<0.01)。结论:不论CK-MB阳性与否,cTn+的NSTE-ACS患者急性期内心脏事件风险均明显增加,而单独的CK-MB阳性对于短期内心脏事件的判断价值有限。RDW水平升高的NSTE-ACS患者急性期内心脏事件风险明显增加,RDW可作为新的危险分层重要标记物。 Objective: To explore creatine kinase-MB (CK-MB) and cardiac troponin (cTn) in patients with non-ST-segment elevation acute coronary syndromes (NSTE-ACS), and investigate the clinical value of red cell distribution width ( RDW ) in these patients. Method . A total of 3 2 0 patients with NSTE ACS were enrolled and dividedintofourgroups(CK-MB /cTn ,CK-MB+ /cTn- ,CK-MB /cTn+ ,CK-MB+ /cTn+ ) according to the results of cardiac injury markers (CK-MB, cTn). These patients were also divided into two groups (H-RDW group and L-RDW group) according to the level of RDW. In-hospital mortality and mobility of heart failure were analyzed. Result:Discordant cardiac injury markers were observed in 24.4 percent of the population, in which 15 % of the patients were CK-MB-/cTn+ , and 9.4% were CK-MB+/cTn . However, there was no significant differ- ence in RDW levels between CK-MB /cTn+ group and CK-MB+/cTn group (P〉0.05). The incidence of heart failure in four groups was 3.4%, 4.4%, 6.8% and 10.30/00 respectively, while in hospital mortality was 0.63%, 0.94%, 1.25% and 2.81% respectively. The incidence of heart failure in H-RDW and L-RDW group was respec- tively 16.9G and 7.5G (P〈0.01), and the in hospital mortality was respectively 3. 75G and 1. 88% (P〈0.01). Conclusion: Regardless of the results of CK-MB, the risk of cardiac events is significantly higher in the NSTE-ACS patients with positive cTn. The value of isolated positive CK-MB is insuffiecent for forecasting the short-term prognosis. Increased RDW levels are closely associated with the risk of cardiac events during the acute period. Thus, RDW may act as a new important cardiac marker in risk classification in NSTE ACS patients.
出处 《临床心血管病杂志》 CSCD 北大核心 2013年第7期512-514,共3页 Journal of Clinical Cardiology
关键词 急性冠状动脉综合征 非ST段抬高 肌酸激酶同工酶 心肌钙蛋白 红细胞分布宽度 non-ST segment elevation acute coronary syndrome creatine kinase-MB cardiac troponin red cell distribution width
  • 相关文献

参考文献13

  • 1NAGAJOTHI N, BRAVERMAN A. Elevated red cell distribution width in the diagnosis of thrombotic thrombocytopenic purpura in patients presenting with anemia and thrombocytopenia [J]. South Med J, 2007,100:257-259.
  • 2DABBAH S, HAMMERMAN H, MARKIEWICZ W, et al. Relation between red cell distribution width and clinical outcomes after acute myocardial infarction [J]. Am J Cardiol, 2010,105: 312 - 317.
  • 3ZALAWADIYA S K, VEERANNA V, NIRAJ A, et al. Red cell distribution width and risk of coronary heart disease events[J]. Am J Cardiol,2010,106:988-993.
  • 4PATEL K V, FERRUCCI L, ERSHLER W B, et al. Red blood cell distribution width and the risk of death in middle-aged and older adults [J]. Arch Intern Med , 2009,169: 515 - 523.
  • 5CHEN P C, SUNG F C, CHIEN K L, et al. Red blood cell distribution width and risk of cardiovascular events and mortality in a community cohort in Taiwan[J]. Am J Epidemiol,2010,171:214-220.
  • 6ANT MAN E M, COHEN M, BERNINK P J, et al. The TIMI risk score for unstable angina/non-ST elevation MI[J]. JAMA,2000 ,284: 835-842.
  • 7ROE M T, MAHAFFEY K W, KILARU R, et al. Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes[J]. Eur Heart J ,2004 ,25: 313- 32l.
  • 8GALLA J M, MAHAFFEY K W, SAPP S K, et al. Elevated creatine kinase-MB with normal creatine kinase predicts worse outcomes in patients with acute coronary syndromes: results from 4 large clinical trials[J]. Am Heart J,2006,151:16-24.
  • 9THYGESEN K, ALPERT J S, WHITE H D. Joint ESC/ ACCF/ AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction[J]. J Am Coll Cardiol, 2007, 50:2173-2195.
  • 10THYGESEN K, ALPERT J S, JAFFE A S, et al. Third Universal Definition of Myocardial Infarction [J]. Circulation, 2012,126: 2020- 2035.

二级参考文献12

  • 1THYGESEN K, ALPERT J S, WHITE H D, et al. Universal definition of myocardial infarction[J]. Circulation, 2007,116 :2634-2653.
  • 2TWERENBOLD R, REICHLIN T, MUELLER C. Clinical application of sensitive cardiac troponin assays: potential and limitations [ J]. Biomark Med, 2010,4:395-401.
  • 3HOCHHOLZER W, BUETrNER H J, TRENK D, et al. New defintion of myocardial infaretion:impact on longterm mortality[J]. Am J Meal,2008,121;399-405.
  • 4EVANGELOS G, KERSTIN K, KLAUS H, et al. Analytical validation of a high-sensitivity cardiac troponin T assay[J]. Clin Chem, 2010,56 : 254-261.
  • 5AMODIO G, ANTONELLI G, VARRASO L, et al. Clinical impact of troponin 99th percentile cut-off and clinical utility of myoglobin measurement in early management of chest pain patients admitted to the Emergency Cardiology Department [J]. Coron Artery Dis, 2007,18 :181-186.
  • 6JAMES S K, LINDAHL B, ARMSTRONG P, et al. A rapid troponin I assay is not optimal for determination of troponin status and predictio/: of subsequent cardiac events at suspicion of unstable coronary syndromes[J]. Int J Cardiol, 2004,93 : 113-120.
  • 7THYGESEN K, ALPERT J S, WHITE H D,et al. Universal definition of myocardial infarction[J]. Circulation, 2007,116 :2634-2653.
  • 8TOBIAS R, WILLIBALD H, STEFANO B, et al. Early Diagnosis of Myocardial Infarction with Sensitive Cardiac Troponin Assays [J]. N Engl J Med, 2009,361 : 858-867.
  • 9WILSON S R, SABATINE M S, BRAUNWALD E, et al. Dectection of myocardial injury in patients withunstable angiana using a novel nanoparticle cardiac troponin I assay: observations from the PROTECTTIMI30 Trial[J]. Am Heart J,2009,158:386-391.
  • 10TELES R, FERREIRA J , AGUIAR C, et al. Prognostic value of cardiac troponin I release kinetics in unstable anginal[J]. Rev Port Cardiol, 2000,19 : 4072 -4221.

共引文献14

同被引文献32

  • 1李学远,田政球,程文林,杜芬.红细胞分布宽度与慢性心力衰竭患者发生恶性心律失常的关系[J].中国老年学杂志,2014,34(11):2950-2951. 被引量:8
  • 2Felker GM, Allen LA, Pocock SJ, et al. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank[J]. J Am Coll Cardiol, 2007, 50(1): 40-47.
  • 3Zalawadiya SK, Veeranna V, Niraj A, et al. Red cell distribution width and risk of coronary heart disease events[J]. Am J Cardiol, 2010, 106(7): 988-993.
  • 4Van Kimmenade RR, Mohammed AA, Uthamalingam S, et al. Red blood cell distribution width and 1-year mortality in acute heart failure[J]. Eur J Heart Fail, 2010, 12(2): 129-136.
  • 5Vaya A, Hernandez JL, Zorio E, et al. Association between red blood cell distribution width and the risk of future cardiovascular events[J]. Clin Hemorheol Microcirc, 2012, 50(3): 221-225.
  • 6Oh J, Kang SM, Hong N, et al. Relation between red cell distribution width with echocardiographic parameters in patients with acute heart failure[J]. J Card Fail, 2009, 15(6): 517-522.
  • 7Borne Y, Smith JG, Melander O, et al. Red cell distribution width in relation to incidence of coronary events and case fatality rates: a population-based cohort study[J]. Heart, 2014, 100(14): 1119-1124.
  • 8Veeranna V, Zalawadiya SK, Panaieh S, et al. Comparative analysis of red cell distribution width and high sensitivity C-reactive protein for coronary heart disease mortality prediction in multi-ethnic population: findings from the 1999-2004 NHANES[J]. Int J Cardiol, 2013, 168(6): 5156-5161.
  • 9Dabbah S, Hammerman H, Markiewicz W, et al. Relation between red cell distribution width and clinical outcomes after acute myocardial infarction[J]. Am J Cardiol, 2010, 105(3): 312-317.
  • 10Huang CH, Chang CC, Kuo CL, et al. Serum iron concentration, but not hemoglobin, correlates with TIMI risk score and 6-month left ventricular performance after primary angioplasty for acute myocardial infarction[J]. PLoS One, 2014, 9(8): e104495.

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部